AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a... (a TNF-aneutralizing antibody also increa...)

HOME >> MEDICINE >> TECHNOLOGY

AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a Signaling

Date:2/11/2008

a TNF-a neutralizing antibody also increases MMP-1 and decreases collagen secretion. However, blocking TNF-a signaling also blocks the BMTd effect.

AGI Dermatics is the developer of Remergent, a doctor-dispensed skincare line based on the science of DNA repair. Pinoxide, an exclusive and patented blend of bicyclic monoterpene diols, is formulated in Remergent Microcirculation Therapy.

About AGI Dermatics

AGI Dermatics is the bio-pharmaceutical laboratory that has led research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell- signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals. http://www.agiderm.com

SOURCE AGI Dermatics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results

Post Your Comments:

(Date:9/5/2008)...Newswire-USNewswire/ -- The Florida,Technology, Re...ida,Atlantic University researcher Dr. Herbert Wei...e Center for Molecular Biology and,Biotechnology i...HS,Resources LLC (CHS), $184,294 as part of the St...ce Grant program (SURECAG). SURECAG was,establishe...

(Date:9/5/2008)...ire-FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ... arthritis data,at the Marcus Evans conference on ...y Dr. Daniel Zimmerman, Senior Vice President of R...that CEL-SCI,s rheumatoid,arthritis vaccine CEL-20...,caused by rheumatoid arthritis in an animal model...

(Date:9/5/2008)...RNewswire-USNewswire/ -- A team of,researchers at ...rants from,India and Pakistan take on the habits o... prostate cancer among male immigrants and breast ...e cancer develop due to many reasons, but,environm...hese cancers,",said Jame Abraham, M.D., medical di...

(Date:9/4/2008)... /- Cytopia Limited (ASX:,CYT) today ...Phase Ib/II,study of CYT997, the company,s novel v...ith an aggressive form of brain cancer known as gl...ial is the first Phase II efficacy study in highly... and the second in its,suite of Phase II studies d...

[0] Major State Grant Accelerates Research and Development of Novel Cancer Therapy [0] Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis [0] Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks [0] Cytopia Commences Second Phase II Study in Brain Cancer

...re-FirstCall/ -- Keryx,Biopharmaceuticals, Inc. to...) (sulodexide oral gelcap) have been selected for,...ions scheduled to,take place at the upcoming Ameri...fic Sessions and exposition at the McCormick Place... these abstracts, which highlight the mechanism of...

...Jun 21, 2007 - Advanced Cell,Technology, Inc. (OTC...nic stem cell (hESC) line without destroying an em...development was announced by,Robert Lanza, M.D., V...nced Cell Technology (ACT) on Tuesday at the fifth...tem Cell Research (ISSCR),in Cairns, Australia., I...

Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 2 Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 3 Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 4 Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 2 Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 3

Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo

(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....

(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...

(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...

(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...

Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2 Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2 Health News:No Place Safe From Allergies 2

[0] Pennsylvania Counties Receive Grants to Improve Services for Children [0] HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services [0] No Place Safe From Allergies [0] Pelosi: America Must Stand Up to Cancer

...r Ranbaxy Laboratories Limited Friday announced th...a patients//. "Ranbaxy has introduced this product... in HFA (Hydroxy fluoro Alkane: the propellant) ba... in two strengths - Osonide 160mcg and Osonide 80m...

...ceive themselves as being fat, despite being norma...ping depression and school-related stress//, repor...d be due to an inclination to Western culture and ...ful'. The researchers surveyed more than 7000 mid...

...ventis SA announced on Thursday that the US Food a...g Taxotere to treat patients with stomach cancer./... combination with chemotherapy drugs cisplatin and...s that have not been treated with chemotherapy. T...

...the sex clinic only report of failing to get arous... present with just the opposite complaints//. Cont...ring from the so-called persistent sexual arousal ...ut unprovoked feelings of excitement. Currently, ...

Other Medicine News:Health News:Obese Chinese Teens Low On Self-Esteem 2

Ranbaxy Launches Once-a-day Inhaler For Asthma Patients Obese Chinese Teens Low On Self-Esteem FDA Gives Green Signal To Sanofi-Aventis SA's Cancer Drug Taxotere Rare Sexual Syndrome In Women Calls For More Research

...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...

Medicine Products:

VZV Antibody, IgM von Willebrand Factor Antigen Vivarin Vivactil

AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a...(a TNF-aneutralizing antibody also increa...),Health